Predicted Trait | |
Reported Trait | Number of medications taken |
Mapped Trait(s) | number of treatments or medications taken, self-reported (EFO_0009803) |
Additional Trait Information | https://biobankengine.stanford.edu/RIVAS_HG19/snpnet/INI137 |
Score Construction | |
PGS Name | GBE_INI137 |
Development Method | |
Name | snpnet |
Parameters | NR |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 8,085 |
Effect Weight Type | NR |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000244 |
Citation (link to publication) | Tanigawa Y et al. PLoS Genet (2022) |
Ancestry Distribution | |
Score Development/Training | European: 100% 269,672 individuals (100%) |
PGS Evaluation | European: 40% African: 20% East Asian: 20% South Asian: 20% 5 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
— | 269,672 individuals | European | UKB | — | — | — | white British ancestry | — |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM007778 | PSS004836| African Ancestry| 6,483 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: # of medications taken | — | — | R²: 0.10873 [0.09444, 0.12301] Incremental R2 (full-covars): -0.00564 PGS R2 (no covariates): 0.00035 [-0.00056, 0.00126] |
age, sex, UKB array type, Genotype PCs | — |
PPM007779 | PSS004837| East Asian Ancestry| 1,702 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: # of medications taken | — | — | R²: 0.10438 [0.07695, 0.1318] Incremental R2 (full-covars): -0.01455 PGS R2 (no covariates): 3e-05 [-0.00047, 0.00053] |
age, sex, UKB array type, Genotype PCs | — |
PPM007780 | PSS004838| European Ancestry| 24,894 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: # of medications taken | — | — | R²: 0.09752 [0.09052, 0.10452] Incremental R2 (full-covars): 0.01417 PGS R2 (no covariates): 0.01416 [0.01125, 0.01708] |
age, sex, UKB array type, Genotype PCs | — |
PPM007781 | PSS004839| South Asian Ancestry| 7,812 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: # of medications taken | — | — | R²: 0.13684 [0.1227, 0.15098] Incremental R2 (full-covars): 0.00757 PGS R2 (no covariates): 0.00724 [0.0035, 0.01098] |
age, sex, UKB array type, Genotype PCs | — |
PPM007782 | PSS004840| European Ancestry| 67,419 individuals |
PGP000244 | Tanigawa Y et al. PLoS Genet (2022) |
Reported Trait: # of medications taken | — | — | R²: 0.08553 [0.0815, 0.08957] Incremental R2 (full-covars): 0.01548 PGS R2 (no covariates): 0.01558 [0.01372, 0.01743] |
age, sex, UKB array type, Genotype PCs | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS004836 | — | — | 6,483 individuals | — | African unspecified | — | UKB | — |
PSS004837 | — | — | 1,702 individuals | — | East Asian | — | UKB | — |
PSS004838 | — | — | 24,894 individuals | — | European | non-white British ancestry | UKB | — |
PSS004839 | — | — | 7,812 individuals | — | South Asian | — | UKB | — |
PSS004840 | — | — | 67,419 individuals | — | European | white British ancestry | UKB | Testing cohort (heldout set) |